Brought to you by 
Lumora Ltd. brings in £1.5mm via Series B round
26 May 2011
Executive Summary
UK molecular diagnostics company Lumora Ltd. raised £1.5mm ($2.4mm) in its Series B financing led by Catapult Venture Managers, which contributed £1mm, with the remaining funds coming from existing shareholder Tate & Lyle Ventures.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Lumora Ltd. brings in £1.5mm via Series B round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice